Form C-AR - Annual Report:
SEC Accession No. 0002085093-26-000005
Filing Date
2026-05-04
Accepted
2026-05-04 12:02:39
Documents
2
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C-AR  
1 primary_doc.xml C-AR 3392
2 ANNUAL REPORT CureValue_Annual_Report_2025.pdf EX-99 1968
  Complete submission text file 0002085093-26-000005.txt   7357
Mailing Address 1207 DELAWARE AVE #826 826 WILMINGTON DE 19806
Business Address 1207 DELAWARE AVE #826 826 WILMINGTON DE 19806 17328608394
CureValue, Inc. (Filer) CIK: 0002085093 (see all company filings)

EIN.: 333746905 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C-AR | Act: 33 | File No.: 020-36540 | Film No.: 26935729